NCT06193044View on ClinicalTrials.gov

Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 7, 2024

Primary Completion Date

July 9, 2024

Study Completion Date

July 12, 2024

Conditions
Healthy Volunteer
Interventions
DRUG

Amlodipine/Valsartan

Amlodipine 10 mg \&valsartan 160 mg

DRUG

Amlodipine 10 mg &valsartan 160 mg (Exforge)

Amlodipine 10 mg \&valsartan 160 mg

Sponsors
All Listed Sponsors
lead

International Bio service

NETWORK